A class of antivirals called Pin1 inhibitors could reduce or stop outbreaks of herpes simplex virus 1 (HSV-1), the common infection behind oral herpes, according to new research published in Antiviral ...

ROCHESTER, N.Y. — Xerox is reducing its workforce as part of its merger with the company Lexmark, a Xerox spokesperson confirmed. Xerox acquired Lexmark, a Kentucky-based imaging and laser printing ...

Diego is a writer and editor with over six years of experience covering games. He's mainly focused on guides, but he's done reviews, features, news, and everything in between. A fan of all genres, you ...

The leading approach to the simplex method, a widely used technique for balancing complex logistical constraints, can’t get any better. In 1939, upon arriving late to his statistics course at the ...

Widely used to prevent infection, one of the active ingredients in the ointment, Neosporin, is neomycin. Discovered in the 1940s, neomycin is an effective topical antibiotic; however, if injected into ...

Blake has over a decade of experience writing for the web, with a focus on mobile phones, where he covered the smartphone boom of the 2010s and the broader tech scene. When he's not in front of a ...

A major shift is unfolding in the field of skin cancer prevention, ignited by new research showing that an everyday vitamin supplement may prevent many cases of the world’s most frequently diagnosed ...

Less than two years ago, a group of the world’s biggest food companies, including Nestle, Danone and Kraft Heinz, announced a major alliance to cut methane emissions from their hundreds of thousands ...

Placing unripe avocados in a paper bag with fruit that gives off ethylene gas ripens them the fastest. Using a ripe banana edged out an apple by two days, but either method works. Heating avocados ...

For the Republic of Korea (ROK, or South Korea), the recent paradigm shift in U.S. policy and alliance relations has been magnified due to an uncanny confluence between South Korea’s domestic ...

Skye Bioscience’s obesity candidate has failed to reduce weight in a phase 2 study, marking another setback for the CB1 inhibitor class. The biotech had been evaluating a 200-mg weekly subcutaneous ...